Match Document Document Title
10657644 Breast cancer detection  
A hybrid detection model may be used for breast cancer detection. A system can identify a region of interest on a received mammogram. The region of interest may have a particular level of grey at...
10656155 Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis  
Biomarkers of pancreatic cancer are described, as well as methods using these compounds for detecting pancreatic cancer. The methods can be used to diagnose a patient's health state, or change in...
10656154 Methods for detecting an amount of complement factor B protein and carbohydrate antigen 19-9 protein, and methods for diagnosing and treating pancreatic cancer using the same  
The present application relates to a kit for diagnosing pancreatic cancer, a method for providing information for diagnosing pancreatic cancer using the kit, and a method for diagnosing pancreatic...
10655187 Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof  
The present invention relates to a gene for predicting or diagnosing the prognosis of early-stage breast cancer and to a use thereof, and more specifically relates to a genetic marker for...
10655186 Point mutations in TRK inhibitor-resistant cancer and methods relating to the same  
Provided herein are methods of treating a subject having a cancer, methods of selecting a treatment for a subject having a cancer, methods of selecting a subject having a cancer for a treatment...
10655184 Methods and compositions involving miR-135b for distinguishing pancreatic cancer from benign pancreatic disease  
Provided are methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.
10655130 Modulation of breast cancer growth by modulation of XBP1 activity  
Described herein is a previously unknown function of XBP1 in triple-negative breast cancer (TNBC). It is shown that XBP1 is preferentially spliced and activated in TNBC, and that deletion of XBP1...
10655121 Galvanotaxis assay for quantitative assessment of metastatic potential of cancer cells  
A system for accelerating and/or inhibiting the migration of cells by applying a time-varying magnetic field to induce eddy currents that promote electrotaxis (galvanotaxis) of cells without the...
10654934 Use of chimeric antigen receptor modified cells to treat cancer  
The present disclosure relates to compositions and methods for compositions, methods, and kits for treating cancer using chimeric antigen receptor (CAR) modified cells. Some embodiments of the...
10654904 Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10654903 Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10654889 Peptide having anticancer activity, and pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and treating cancer comprising the same as active ingredient  
The present invention relates to a peptide having anticancer activity, and a pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and...
10654884 Purine derivatives as CD73 inhibitors for the treatment of cancer  
Provided are novel purine nucleoside/nucleotide analogues compounds, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are inhibitors of CD73 and are useful...
10654877 Dioxolane analogues of uridine for the treatment of cancer  
The invention provides compounds of the formula: R1 is OR11, or NR5R5′;R2 is H or F;R5 is H, C1-C6alkyl, OH, C(═O)R6, O(C═O)R6 or O(C═O)OR6;R5′ is H or C1-C6alkyl;R6 is C1-C6alkyl or...
10654811 Heterocyclic compounds for cancer imaging and treatment and methods for their use  
Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, X, n1, n2, and n3 are as defined...
10653751 Methods of treating cancer metastasis by using interleukin-10  
Methods of treating subjects having a disease or disorder responsive to IL-10, including methods of administration and dosing regimens associated therewith, are provided.
10653735 Uses of Mesembryanthemum crystallinum L. callus extract in delaying skin cell aging, nursing skin, treating and preventing skin cancer  
Use of Mesembryanthemum crystallinum L. callus extract in the manufacture of a medicament or a skin care product, wherein the medicament or skin care product is for at least one of delaying skin...
10653705 Applications for estrone in preparing anti-ovarian cancer and/or breast cancer products  
This invention discloses uses for estrone in preparing anti-ovarian cancer and/or breast cancer products. This invention provides uses for estrone in the preparation of products to treat ovarian...
10653651 Kit for treating cancer with low molecular weight components of aurin tricarboxylic acid complex  
A method of preventing and/or treating cancer in a subject is provided. The method includes administering to the subject a composition comprising an effective amount of an active agent selected...
10653638 Pimarane diterpenoids for use in cancer treatment  
A pimarane diterpenoid, having the following structure: or a tautomer thereof in which R1 and R2 are independently selected from —H, C1-10 alkyl, C1-10 alkoxy, C1-10 alkenyl, C1-10 alkenoxy, —OH,...
10653357 Device, method and system for implementing a physical area network for cancer immunotherapy  
A physical area network described herein enables significantly improved health monitoring and treatment by utilizing internal (in-body) mechanisms and information and external mechanisms and...
10648983 Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies  
A method of identifying a subject having cancer who is likely to be responsive to a treatment compound, comprising administering the treatment compound to the subject having the cancer; obtaining...
10648040 Immune gene signatures in treating breast cancer  
This invention relates to methods for treating subjects with breast cancer, based on tumor expression levels of chemokines.
10648039 Use of methylation sites in Y chromosome as prostate cancer diagnosis marker  
Disclosed is a use of methylation sites as a disease diagnosis marker, in particular relating to a use of methylation sites in a Y chromosome as a prostate cancer diagnosis marker. More...
10648036 Receptor gene for peptide cancer antigen-specific T cell  
The invention provides the nucleotide sequence and amino acid sequence of the CDR3 domain of the T cell receptor (TCR) gene of a WT1-specific cytotoxic T cell (CTL) against WT1 protein. Also...
10648035 Methods and compositions for diagnosing and treating gastric cancer  
The present invention relates to the field of gastric cancer. More specifically, the present invention provides methods and compositions for diagnosing and treating gastric cancer. In a specific...
10647707 Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer  
Provided herein are benzimidazole derivatives, for example, of Formula I, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or...
10647686 Substituted pyrimidines for preventing or treating cancer and inflammatory diseases  
The present invention relates to compounds represented by Formula 1 or a pharmaceutically acceptable salt thereof,wherein:R1 is chloro or methyl;R2 is hydrogen or chloro;R3 is hydrogen, fluoro,...
10646567 Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors  
The present invention describes combination treatment comprising a PD-1 axis binding antagonist and a MEK inhibitor and methods for use thereof, including methods of treating conditions where...
10646532 Method for preparing water extract of ashwagandha leaves which has enhanced anti-cancer activity utilizing cyclodextrin, and pharmaceutical composition containing ashwagandha leaves  
It is an object of the present invention to provide a method for preparing a water extract of ashwagandha, which comprises increasing the amounts of withanone and withaferin A contained as active...
10646521 Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment  
The present invention provides methods for determining if a patient is likely to benefit from a cancer treatment, by determining if said patient has a gut dysbiosis with an over representation of...
10646479 Use of N-(4-iodobenzoylamino)-5-ethyl-1,2,3,6-tetrahydropyridine as a treatment for cancer  
Disclosed herein is the use of N-(4-iodobenzoylamino)-5-ethyl-1,2,3,6-tetra-hydropyridine as a treatment for cancer.
10646474 Glucocorticoid receptor modulators to treat pancreatic cancer  
Methods and compositions for treating a subject hosting a non-ACTH-secreting pancreatic tumor are disclosed. The methods include administering to the subject a chemotherapeutic agent and a...
10646465 Small molecules against cancer  
Compounds capable of, or usable in, killing cancer cells, and/or modulating a biological activity of a chemokine, and/or inhibiting a kinase, and/or treating diseases and disorders associated with...
10646464 Methods for treating cancer  
Methods for treating advanced thymoma and thymic carcinoma in a subject comprising administering and kits comprising at least one paclitaxel compound and at least one compound of formula (I)...
10646460 Pharmaceutical composition for inhibiting growth of cancer stem cells, containing aldehyde inhibitor and biguanide-based compound  
The present invention relates to a pharmaceutical composition for inhibiting growth of cancer stem cells, containing an aldehyde inhibitor and a biguanide-based compound. The pharmaceutical...
10641774 Method for diagnosing cancer by detecting C-terminal segment of moesin in blood  
A method for assessing cancer comprising obtaining a biological sample of the subject, detecting a level of a C-terminal segment of moesin in the biological sample, wherein the level of the...
10640831 Biomarkers for head and neck cancer and methods of their use  
Disclosed is a diagnostic panel of methylated genomic loci encoding microRNA (mgmiR) markers that demonstrated 90% sensitivity and 100% specificity in the detection of head and neck squamous cell...
10640830 Drug selection for non-small cell lung cancer therapy  
The present invention provides methods for selecting a suitable anticancer drug for the treatment of patient with non-small cell lung cancer (NSCLC). The present invention also provides methods...
10640567 Anti-CD40 antibodies and methods of treating cancer having CD40+ tumor cells  
The present invention relates to antibodies (and fragments, variants, fusions and derivatives thereof) with multivalent binding specificity for CD40, which have a potency for dendritic cell...
10640535 Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies  
The present invention describes novel tumor-specific phosphorylated peptides, nucleic acids encoding those peptides, and antibodies generated against said peptides. The genes, peptides, and...
10640524 Prototype systems of theranostic biomarkers for in vivo molecular management of cancer  
The present invention relates to a theranostic system comprising a beacon and a compound selected from the group consisting of a quinazoline-based tyrosine kinase inhibitor and a natural product....
10640493 Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer  
This invention provides, among other things, compounds useful for treating diseases such as cancer, pharmaceutical formulations containing such compounds, as well as combinations of these...
10639363 Cancer immunotherapy using virus particles  
A method of treating cancer in a subject in need thereof includes administering in situ to the cancer a therapeutically effective amount of a virus or virus-like particle.
10639348 Peptides with anti-cancer activity  
The peptides of the invention are of formula (I) or (IV). The peptides of the invention are useful in the treatment of cancer.
10639338 Traditional Chinese medicine composition for treating prostate cancer, preparation method and application thereof  
The present invention relates to a traditional Chinese medicine composition for treating prostate cancer and its preparation method and application. The composition is prepared from Ganoderma...
10639337 Method for treating cancer with a Coxsackievirus B3 (CVB3) variant  
The present invention relates to a method for treating cancer in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a Coxsackie B3 group...
10639332 Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10639331 Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10639329 Method to treat cancer with engineered T-cells  
Novel adoptive immunotherapy compositions comprising co-cultured lentiviral vector-transduced autologous antigen presentation cells and T cells are provided herein as well as are methods of use of...

卡通 自拍 亚洲 另类